Compare HLN & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLN | BDX |
|---|---|---|
| Founded | 2022 | 1897 |
| Country | United Kingdom | United States |
| Employees | 24524 | N/A |
| Industry | Package Goods/Cosmetics | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5B | 43.0B |
| IPO Year | N/A | 1998 |
| Metric | HLN | BDX |
|---|---|---|
| Price | $9.87 | $178.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $186.00 |
| AVG Volume (30 Days) | ★ 11.1M | 1.8M |
| Earning Date | 02-26-2026 | 05-07-2026 |
| Dividend Yield | 1.94% | ★ 2.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.59 |
| Revenue | N/A | ★ $21,840,000,000.00 |
| Revenue This Year | $6.55 | N/A |
| Revenue Next Year | $4.42 | $3.02 |
| P/E Ratio | ★ $49.05 | $111.23 |
| Revenue Growth | N/A | ★ 8.24 |
| 52 Week Low | $8.65 | $140.11 |
| 52 Week High | $11.28 | $213.08 |
| Indicator | HLN | BDX |
|---|---|---|
| Relative Strength Index (RSI) | 51.34 | 70.00 |
| Support Level | $9.56 | $163.44 |
| Resistance Level | $10.06 | $196.05 |
| Average True Range (ATR) | 0.17 | 3.78 |
| MACD | -0.03 | 1.40 |
| Stochastic Oscillator | 35.51 | 86.84 |
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.